COVID-19 pandemic accelerated adoption of shorter, lower-burden (lower cost) breast radiation therapy
The COVID-19 pandemic accelerated the adoption of shorter-course radiation therapy for women with early-stage breast cancer, leading to reduced treatment burden and lower health care spending, according to a new study published in the American Journal of Clinical Oncology.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.